Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination

Biological Psychiatry

Volumn 51, Issue 2, 2002, Pages 123-133

  Hirschfeld, Robert M A ^a   Dunner, David L ^b   Keitner, Gabor ^c   Klein, Daniel N ^d   Koran, Lorrin M ^e   Kornstein, Susan G ^f   Markowitz, John C ^g   Miller, Ivan ^c   Nemeroff, Charles B ^h   Ninan, Philip T ^h   Rush, A John ⁱ   Schatzberg, Alan F ^e   Thase, Michael E ^j   Trivedi, Madhukar H ⁱ   Borian, Frances E ^k   Crits Christoph, Paul ^l   Keller, Martin B ^m  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BROWN UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j UNIVERSITY OF PITTSBURGH   (United States)

^k BRISTOL MYERS SQUIBB   (United States)

^l UNIVERSITY OF PENNSYLVANIA   (United States)

^m BROWN UNIVERSITY   (United States)

more..

Author keywords

Chronic major depression; Combined treatment; Nefazodone; Psychosocial functioning; Psychotherapy

Indexed keywords

NEFAZODONE;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SOCIAL ASPECT; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME; WORK CAPACITY;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHRONIC DISEASE; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; SOCIAL ADJUSTMENT; TREATMENT OUTCOME; TRIAZOLES;

EID: 0037081370     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(01)01291-4     Document Type: Article

References (34)

1. Practice guidelines for major depressive disorder in adults
2. Endicott Work Productivity Scale (EWPS): A new measure to assess treatment effects
3. Clinical management - Imiramine/placebo administration manual
4. Development of a rating scale for primary depressive illness
5. Pharmacotherapy of dysthymic disorder
6. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses
7. A phase model of psychotherapy outcome: Causal mediation of change
8. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder
9. The treatment of chronic depression, part 2: A double-blind, randomized trial of sertraline and imipramine
10. Summary of the DSM-IV mood disorders field trial and issue overview
11. Maintenance phase efficacy of sertraline for chronic depression: A randomized controlled trial
12. The longitudinal interval follow-up evaluation: A comprehensive method for assessing outcome in prospective longitudinal studies
13. A comparison of nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, and their combination for the treatment of chronic depression
14. Imipramine treatment for chronic depression
15. Maintenance therapy for chronic depression: A controlled clinical trial of desipramine
16. Sertraline versus imipramine to prevent relapse in chronic depression
17. Interpersonal improvement in chronically depressed patients treated with desipramine
18. Comparison of the costs and quality of norms for the SF-36 Health Survey collected by mail versus telephone interview: Results from a national survey
19. The treatment of chronic depression, part 3: Psychosocial functioning before and after treatment with sertraline or imipramine
20. Social adjustment and depression: A longitudinal study
21. Utility of a new procedure fordiagnosing mental disorders in primary care: The PRIME-MD 1000 Study
22. Social functioning in chronic depression: Effects of 6 weeks of antidepressant treatment
23. A placebo-controlled randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia
24. The MOS 36-Item Short-Form Health Survey (SF-36)
25. A comparison of three scales for assessing social functioning in primary care
26. Social adjustment by self-report in a community sample and psychiatric outpatients
27. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study